Hemoglobinopati Prevelansı- Bir Üçüncü Basamak Merkez Deneyimi

Objective & Hypothesis:Amaç: Haryana şehrindeki talasemi ve diğer hemoglobinopatilerin prevelansını ortaya çıkarmak ve bu hastalıkların hızlı ve doğru tanısında yüksek performans likid kromatografi (HPLC)’nin rolünü araştırmak.

📊

Key Findings & Data:Yöntemler: Bu çalışma çok dilimli random örnekleme metoduyla toplam 4275 hastanın HPLC cihazıyla varyantlarının gösterilmesi vasıtasıyla Temmuz-Ekim 2010 tarihleri arasında Pt.

💡

Conclusion & Impact:Sonuç: Bu bölgede yüksek hemoglobinopati prevelansı saptandı ve HPLC çeşitli hemoglobinopatilerin erken saptanmasında hızlı ve kesin bir yöntemdir.

🔬Design:Experimental Field Trial

📍Scope:2010 · 4275 hasta

⚙️Variables:Domain Parameters

Abstract

Amaç: Haryana şehrindeki talasemi ve diğer hemoglobinopatilerin prevelansını ortaya çıkarmak ve bu hastalıkların hızlı ve doğru tanısında yüksek performans likid kromatografi (HPLC)’nin rolünü araştırmak. Yöntemler: Bu çalışma çok dilimli random örnekleme metoduyla toplam 4275 hastanın HPLC cihazıyla varyantlarının gösterilmesi vasıtasıyla Temmuz-Ekim 2010 tarihleri arasında Pt. B. D. Sharma, PGIMS, Rohtak’da gerçekleştirilmiştir. Bulgular: Toplam 4275 vakanın 3862’si (%90,3) normal bir hemoglobin paterni gösterirken, 413 vakada (%9,7) anormal hemoglobin fraksiyonları HPLC ile saptandı. Anormal vakaların 318’i (%7,4) beta (β) talasemi idi. Vakaların 19’u β-talasemi major ve 24 ‘ü β-talasemi intermedia olarak tespit edildi. Diğer anormal durumların altısı HbE’li, ikisi HbS’li, ikisi HbF’li, 11’I HbD’li, biri HbC’li ve iki vakanın her biri Hb E/ β-taalasemi ve Hb S/ β-talasemi heterozigot idi. Sonuç: Bu bölgede yüksek hemoglobinopati prevelansı saptandı ve HPLC çeşitli hemoglobinopatilerin erken saptanmasında hızlı ve kesin bir yöntemdir.

Özet

Objective: To find out the prevalence of thalassemias and various other hemoglobinopathies in state of Haryana and toassess the role of High performance liquid chromatography (HPLC) for accurate and quick diagnosis of varioushemoglobin disorders.Methods: This study was conducted in Pt. B. D. Sharma, PGIMS, Rohtak from July 2010 to October 2016 forhemoglobin variant screening by HPLC of total of 4275 patients, selected through multistage random samplingtechnique.Results: Among 4275 total cases surveyed, normal hemoglobin pattern was observed in 3862 (90.3%) and abnormalhemoglobin fractions on HPLC were detected in 413 (9.7%). Βeta (β) thalassemia trait was predominant abnormalityfound in a total of 318 cases (7.4%). There were 19 cases of β-thalassemia major and 24 of β-thalassemia intermedia.Other abnormal patterns found were HbE (trait in 11 and HbE disease in 6 cases), Hb S (2 cases each of sickle celldisease and sickle cell trait), 2 cases of high Hb F (1 case each of heterozygous and homozygous HPFH), 11 cases of HbD Punjab along with 2 cases of Hb D Iran, 1 case of Hb C and 2 cases each of double heterozygotes for Hb E/ βthalassemia and Hb S/ β-thalassemia.Conclusion: There is high prevalence of hemoglobinopathies in this region and HPLC forms a rapid and accurate toolin early detection and management of various hemoglobinopathies.

🔖

Cite This Article

JAIN, P., GUPTA, M., DUA, S., MARWAH, N., GILL, M., SEN, R. (2019). Hemoglobinopati Prevelansı- Bir Üçüncü Basamak Merkez Deneyimi. Dicle Tıp Dergisi, Cilt: 46 - Sayı: 2, 269–276. https://ajindex.com/articles/343737

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Edward J. Benz Jr. Disorders of Hemoglobin Chapter 104, in Harrision’s Principle of Internal Medicine, 18th edition, 2011; 1: 852-61. 2. Tyagi S, Saxena R, Choudhry VP. HPLC--how necessary is it forhaemoglobinopathy diagnosis in India? Indian J Pathol Microbiol 2003; 46: 390-3. 3. WHO- EXECUTIVE BOARD EB118/5, 118th Session Report by the Secretariat on Thalassemia and other hemoglobinopathies: Prevalence of Hemoglobinopathies. 11 May 2006,p1-8. 4. Balgir RS. The genetic burden of hemoglobinopathies with special reference to community health in India and the challenges ahead. Indian Journal of Hematology and Blood Transfusion. 2002; 20: 2-7. 5. Joutovsky A, Hadzi-Nesic J, Nardi M. HPLC retention time as diagnostic tool for hemoglobin variants and hemoglobinopathies: A study of 60,000 samples in clinical diagnostic laboratory. Clinical chemistry. 2004; 50: 1736- 47. 6. Alamiry AAN, Ali TH, Majeed MN. Detection of hemoglobinopathies in hypochromic, microcytic and sickeled cell blood films by haemoglobin electrophoresis. Thi-Qar medical journal (TQMJ): 2011; 5: 139-48. 7. Bravo-Urquiola M, Arends A, Montilla S, et all. Advantages in the use of high performance chromatography technique for screening hemoglobinopathies in Venezuela. Invest Clin2004; 45: 309-15. 8. Verma P, Ghildiyal A, Verma D, et all. Prevalence of hemoglobinopathies in different regions and castes of Uttar Pradesh, India- A hospital based study. Asian J Med Sci 2015; 6: 21-5. 9. Mondal SK, Dasgupta S, Mondal S, Das N. Spectrum of thalassemias and hemoglobinopathies in West Bengal: A study of 90,210 cases by cation exchange high performance liquid chromatography method over a period of 8 years. J Applied Hemat 2014; 5: 91-5. 10. Jain BB, Roy RN, Ghosh S, et all. Screening for thalassemia and other hemoglobinopathies in tertiary care hospital of West Bengal: Implications for population screening. Indian J Public Health 2012; 56: 297-300. 11. Patel U, Shrivastav A, Joshi JR, et all. Detection of hemoglobinopathies and thalassemias in population of Gujarat State using HPLC: analysis of 2022 cases. Pathology and laboratory medicine 2012; 4: 80-4. 12. Madan N, Sharma S, Sood SK, Colah R, Bhatia LH. Frequency of Beta thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet 2010; 16: 16-25. 13. Sachdev R, Dam AR, Tyagi G. Detection of Hb variants and hemoglobinopathies in indian population using HPLC: report of 2600 cases. Indian J Path Micro 2010; 53: 57-62.